Articles | 24th November 2022 | 3 mins read

Learning to manage the risks involved in high potency drugs manufacturing

Mark Arnold, MD of ONFAB, describes the challenges in handling HPAPIs and how pharma manufacturers can learn to manage the risk involved.

Read on
The antibody with drug conjugated cytotoxic payload for drug carrier or delivery 1412959809 2400x2000